SCHEMBL310780

SCHEMBL310780

OB(O)c1ccc(Cl)c(F)c1

nearest known ligand 0.57

Predicted protein targets (top 8)

geneUniProtsupporting neighboursconfidence
TTR P02766 3/20 0.50
ENPP2 Q13822 4/20 0.46
CA1 P00915 2/20 0.40
CA2 P00918 2/20 0.40
EGFR P00533 1/20 0.39
MGLL Q99685 2/20 0.37
KMO O15229 1/20 0.37
TSHR P16473 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29465759 1.00 TTR (0.50) TTRENPP2CA1CA2EGFR
SCHEMBL9872898 0.98 TTR (0.48) TTRENPP2CA1CA2EGFR
SCHEMBL2407029 0.86 TRPV6 (0.46) TTRENPP2KMO
SCHEMBL31333 0.82 TTR (0.55) TTRENPP2CA1CA2EGFR
SCHEMBL128893 0.78 ENPP2 (0.46) TTRENPP2CA1CA2MGLL
SCHEMBL130450 0.78 TTR (0.61) TTRENPP2CA1CA2TSHR
SCHEMBL28490899 0.76 ENPP2 (0.44) TTRENPP2CA1CA2MGLL
SCHEMBL9872902 0.76 RAPGEF4 (0.33) KMO
SCHEMBL423468 0.74 ENPP2 (0.44) TTRENPP2CA1CA2MGLL
SCHEMBL15646351 0.74 CA2 (0.42) TTRENPP2CA1CA2MGLL

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 957 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250194617-A1 Materials and Methods for Extending Shelf-Life of Foods JP LABORATORIES, INC. 2025-06-19 US claimed
US-20250169514-A1 Materials and Methods for Extending Shelf-Life of Foods JP LABORATORIES, INC. 2025-05-29 US claimed
WO-2024016826-A1 6-POSITION SUBSTITUTED DIHYDROBENZO[E][1,2,3]OXATHIAZINE 2,2-DIOXIDE COMPOUND, PREPARATION THEREFOR, AND USE THEREOF 杭州市第七人民医院 2024-01-25 WO claimed
US-20230380457-A1 Materials and Methods for Extending Shelf-Life of Foods JP LABORATORIES, INC. 2023-11-30 US claimed
EP-4280882-A2 MATERIALS AND METHODS FOR EXTENDING SHELF-LIFE OF FOODS JP LABORATORIES, INC. (US) 2023-11-29 EP claimed
US-20230363426-A1 Materials and Methods for Extending Shelf-Life of Foods JP LABORATORIES, INC. 2023-11-16 US claimed
US-11793220-B2 Materials and methods for extending shelf-life of foods JP LABORATORIES, INC. (US) 2023-10-24 US claimed
CN-116916755-A Materials and methods for extending the shelf life of food products JP实验室公司 2023-10-20 CN claimed
CN-115232090-A 6-substituted dihydrobenzo [ e ] [1,2,3] oxathiazine 2,2-dioxide compound and preparation and application thereof 杭州市第七人民医院 2022-10-25 CN claimed
US-20220264914-A1 MATERIALS AND METHODS FOR EXTENDING SHELF-LIFE OF FOODS JP LABORATORIES, INC. 2022-08-25 US claimed
US-20220225647-A1 MATERIALS AND METHODS FOR EXTENDING SHELF-LIFE OF FOODS JP LABORATORIES, INC. 2022-07-21 US claimed
US-20220225646-A1 MATERIALS AND METHODS FOR EXTENDING SHELF-LIFE OF FOODS JP LABORATORIES, INC. 2022-07-21 US claimed
WO-2026106260-A1 NOVEL DIPHENYLETHER DERIVATIVE AND USE THEREOF 광주과학기술원 2026-05-21 WO disclosed
EP-3856179-B1 MONOACYLGLYCEROL LIPASE MODULATORS JANSSEN PHARMACEUTICA NV (BE) 2026-05-13 EP disclosed
EP-3704096-B1 MODULATORS OF THE INTEGRATED STRESS PATHWAY CALICO LIFE SCIENCES LLC (US) 2026-04-22 EP disclosed
US-20260103459-A1 SUBSTITUTED AZACYLES AS TRPM8 MODULATORS GIVAUDAN SA (CH) 2026-04-16 US disclosed
WO-1991009016-A2 HALOPHENYL SUBSTITUTED HETEROCYCLIC DERIVATIVES MERCK PATENT GMBH (DE) 1991-06-27 WO disclosed
WO-1991009016-A1 HALOPHENYL SUBSTITUTED HETEROCYCLIC DERIVATIVES MERCK Patent Gesellschaft mit beschränkter Haftung (DE) 1991-06-27 WO disclosed
EP-0428666-A1 FLUORO-CHLORO-BENZENE DERIVATIVES. MERCK PATENT GMBH (DE) 1991-05-29 EP disclosed
WO-1990015113-A1 FLUORO-CHLORO-BENZENE DERIVATIVES MERCK Patent Gesellschaft mit beschränkter Haftung (DE) 1990-12-13 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260103459-A1 SUBSTITUTED AZACYLES AS TRPM8 MODULATORS TRPM8, TRPM7, TRPM5 TTR 4654/4885ENPP2 4310/4885CA1 739/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.